BioCentury
ARTICLE | Company News

Xenon, Merck deal

June 15, 2009 7:00 AM UTC

Merck and Xenon partnered to discover and develop small molecules to treat cardiovascular disease. Xenon will perform drug discovery and preclinical development of candidates for an undisclosed number...